Your browser doesn't support javascript.
loading
Fixing the Leaky Pipe: How to Improve the Uptake of Patient-Reported Outcomes-Based Prognostic and Predictive Models in Cancer Clinical Practice.
Spencer, Katie L; Absolom, Kate L; Allsop, Matthew J; Relton, Samuel D; Pearce, Jessica; Liao, Kuan; Naseer, Sairah; Salako, Omolola; Howdon, Daniel; Hewison, Jenny; Velikova, Galina; Faivre-Finn, Corinne; Bekker, Hilary L; van der Veer, Sabine N.
Affiliation
  • Spencer KL; Leeds Institute of Health Sciences, University of Leeds, Leeds, United Kingdom.
  • Absolom KL; Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.
  • Allsop MJ; Leeds Institute of Health Sciences, University of Leeds, Leeds, United Kingdom.
  • Relton SD; Leeds Institute of Health Sciences, University of Leeds, Leeds, United Kingdom.
  • Pearce J; Leeds Institute of Data Analytics, University of Leeds, Leeds, United Kingdom.
  • Liao K; Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.
  • Naseer S; Leeds Institute of Medical Research, University of Leeds, Leeds, United Kingdom.
  • Salako O; Division of Informatics, Imaging and Data Sciences, Faculty of Biology, Medicine and Health, Centre for Health Informatics, Manchester Academic Health Science Centre, The University of Manchester, Manchester, United Kingdom.
  • Howdon D; School of Medicine, University of Leeds, Leeds, United Kingdom.
  • Hewison J; College of Medicine, University of Lagos, Lagos, Nigeria.
  • Velikova G; Leeds Institute of Health Sciences, University of Leeds, Leeds, United Kingdom.
  • Faivre-Finn C; Leeds Institute of Health Sciences, University of Leeds, Leeds, United Kingdom.
  • Bekker HL; Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.
  • van der Veer SN; Leeds Institute of Medical Research, University of Leeds, Leeds, United Kingdom.
JCO Clin Cancer Inform ; 7: e2300070, 2023 Sep.
Article in En | MEDLINE | ID: mdl-37976441
PURPOSE: This discussion paper outlines challenges and proposes solutions for successfully implementing prediction models that incorporate patient-reported outcomes (PROs) in cancer practice. METHODS: We organized a full-day multidisciplinary meeting of people with expertise in cancer care delivery, PRO collection, PRO use in prediction modeling, computing, implementation, and decision science. The discussions presented here focused on identifying challenges to the development, implementation and use of prediction models incorporating PROs, and suggesting possible solutions. RESULTS: Specific challenges and solutions were identified across three broad areas. (1) Understanding decision making and implementation: necessitating multidisciplinary collaboration in the early stages and throughout; early stakeholder engagement to define the decision problem and ensure acceptability of PROs in prediction; understanding patient/clinician interpretation of PRO predictions and uncertainty to optimize prediction impact; striving for model integration into existing electronic health records; and early regulatory alignment. (2) Recognizing the limitations to PRO collection and their impact on prediction: incorporating validated, clinically important PROs to maximize model generalizability and clinical engagement; and minimizing missing PRO data (resulting from both structural digital exclusion and time-varying factors) to avoid exacerbating existing inequalities. (3) Statistical and modeling challenges: incorporating statistical methods to address missing data; ensuring predictive modeling recognizes complex causal relationships; and considering temporal and geographic recalibration so that model predictions reflect the relevant population. CONCLUSION: Developing and implementing PRO-based prediction models in cancer care requires extensive multidisciplinary working from the earliest stages, recognition of implementation challenges because of PRO collection and model presentation, and robust statistical methods to manage missing data, causality, and calibration. Prediction models incorporating PROs should be viewed as complex interventions, with their development and impact assessment carried out to reflect this.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplasms Limits: Humans Language: En Journal: JCO Clin Cancer Inform Year: 2023 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplasms Limits: Humans Language: En Journal: JCO Clin Cancer Inform Year: 2023 Document type: Article Affiliation country: Country of publication: